Moreira Danielle P, Griesi-Oliveira Karina, Bossolani-Martins Ana L, Lourenço Naila C V, Takahashi Vanessa N O, da Rocha Kátia M, Moreira Eloisa S, Vadasz Estevão, Meira Joanna Goes Castro, Bertola Debora, O'Halloran Eoghan, Magalhães Tiago R, Fett-Conte Agnes C, Passos-Bueno Maria Rita
Centro de Pesquisas sobre o Genoma Humano e Células Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brasil.
Departamento de Biologia Molecular, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, SP, Brasil.
PLoS One. 2014 Sep 25;9(9):e107705. doi: 10.1371/journal.pone.0107705. eCollection 2014.
Copy number variations (CNVs) are an important cause of ASD and those located at 15q11-q13, 16p11.2 and 22q13 have been reported as the most frequent. These CNVs exhibit variable clinical expressivity and those at 15q11-q13 and 16p11.2 also show incomplete penetrance. In the present work, through multiplex ligation-dependent probe amplification (MLPA) analysis of 531 ethnically admixed ASD-affected Brazilian individuals, we found that the combined prevalence of the 15q11-q13, 16p11.2 and 22q13 CNVs is 2.1% (11/531). Parental origin could be determined in 8 of the affected individuals, and revealed that 4 of the CNVs represent de novo events. Based on CNV prediction analysis from genome-wide SNP arrays, the size of those CNVs ranged from 206 kb to 2.27 Mb and those at 15q11-q13 were limited to the 15q13.3 region. In addition, this analysis also revealed 6 additional CNVs in 5 out of 11 affected individuals. Finally, we observed that the combined prevalence of CNVs at 15q13.3 and 22q13 in ASD-affected individuals with epilepsy (6.4%) was higher than that in ASD-affected individuals without epilepsy (1.3%; p<0.014). Therefore, our data show that the prevalence of CNVs at 15q13.3, 16p11.2 and 22q13 in Brazilian ASD-affected individuals is comparable to that estimated for ASD-affected individuals of pure or predominant European ancestry. Also, it suggests that the likelihood of a greater number of positive MLPA results might be found for the 15q13.3 and 22q13 regions by prioritizing ASD-affected individuals with epilepsy.
拷贝数变异(CNV)是自闭症谱系障碍(ASD)的一个重要病因,位于15q11-q13、16p11.2和22q13的CNV据报道最为常见。这些CNV表现出可变的临床表型,位于15q11-q13和16p11.2的CNV也表现出不完全外显率。在本研究中,通过对531名具有种族混合背景的巴西自闭症患者进行多重连接依赖探针扩增(MLPA)分析,我们发现15q11-q13、16p11.2和22q13 CNV的合并患病率为2.1%(11/531)。在8名受影响个体中可以确定亲本来源,结果显示其中4个CNV代表新生事件。基于全基因组SNP阵列的CNV预测分析,这些CNV的大小范围从206 kb到2.27 Mb,位于15q11-q13的CNV局限于15q13.3区域。此外,该分析还在11名受影响个体中的5名中发现了另外6个CNV。最后,我们观察到,患有癫痫的自闭症患者中,15q13.3和22q13处CNV的合并患病率(6.4%)高于无癫痫的自闭症患者(1.3%;p<0.014)。因此,我们的数据表明,巴西自闭症患者中15q13.3、16p11.2和22q13处CNV的患病率与纯欧洲血统或主要为欧洲血统的自闭症患者的估计患病率相当。此外,这表明通过对患有癫痫的自闭症患者进行优先排序,在15q13.3和22q13区域可能会发现更多阳性MLPA结果。